Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

239.62

+2.67 (1.13%)

At close: Jul 22, 2026, 4:00 PM EDT

239.49

-0.13 (-0.05%)

Pre-market: Jul 23, 2026, 4:47 AM EDT

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	12,331	9,293	4,118	3,769	3,355	1,429
Market Cap Growth	124.21%	125.69%	9.26%	12.33%	134.83%	-53.08%
Enterprise Value	12,246	9,186	3,994	3,569	3,249	1,392
Last Close Price	239.62	182.64	84.61	79.59	77.13	37.78
PS Ratio	17.41	14.55	10.68	13.93	67.05	-
PB Ratio	225.72	105.25	72.22	19.73	30.62	91.41
P/TBV Ratio	3351.44	254.26	-	28.77	79.22	90.93
EV/Sales Ratio	17.29	14.39	10.36	13.19	64.93	-
Debt / Equity Ratio	3.96	2.44	3.33	0.97	0.86	3.14
Net Debt / Equity Ratio	-1.62	-1.22	-2.17	-1.05	-0.97	-2.35
Net Debt / EBITDA Ratio	0.54	0.68	0.45	0.89	0.61	0.30
Net Debt / FCF Ratio	1.25	1.14	0.96	1.37	0.91	0.34
Asset Turnover	1.01	1.01	0.67	0.59	0.24	0
Inventory Turnover	1.76	2.17	2.16	2.68	2.41	-
Quick Ratio	1.27	1.44	1.99	3.46	2.47	3.75
Current Ratio	1.39	1.55	2.11	3.63	2.54	3.75
Return on Equity (ROE)	-263.58%	-252.12%	-231.63%	-159.21%	-298.97%	-201.51%
Return on Assets (ROA)	-24.60%	-26.43%	-48.52%	-50.62%	-85.77%	-91.05%
Return on Capital Employed (ROCE)	-59.16%	-51.36%	-71.23%	-67.76%	-120.01%	-109.67%
Buyback Yield / Dilution	-4.24%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%
Total Shareholder Return	-4.24%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%

SEC Filings: 10-K · 10-Q